Trial intelligence / Profile preview

ACYW135 meningococcal conjugate vaccine in infants

CTR20202577Phase 3Completed

Sponsor
Yuxi Watson Biotechnology
Start
Dec 2020
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of meningococcal groups a, c, y and w135 polysaccharide conjugate vaccine in meningococcal meningitis, sponsored by Yuxi Watson Biotechnology. Started Dec 2020; status: completed.

02

Drugs

meningococcal groups a, c, y and w135 polysaccharide conjugate vaccine
03

Conditions

meningococcal meningitis

Beyond the preview

Go deeper on CTR20202577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20202577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call